$ELAN
Elanco Animal Health Inc

2024 Q3 Form 10-Q Financial Statement

#000173910424000027 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $1.030B $1.184B
YoY Change -3.56% 12.02%
Cost Of Revenue $492.0M $495.0M
YoY Change 1.03% 14.06%
Gross Profit $538.0M $689.0M
YoY Change -7.4% 10.59%
Gross Profit Margin 52.23% 58.19%
Selling, General & Admin $323.0M $354.0M
YoY Change 3.19% 0.28%
% of Gross Profit 60.04% 51.38%
Research & Development $87.00M $89.00M
YoY Change 1.16% 9.88%
% of Gross Profit 16.17% 12.92%
Depreciation & Amortization $170.0M $162.0M
YoY Change -1.73% -8.47%
% of Gross Profit 31.6% 23.51%
Operating Expenses $410.0M $443.0M
YoY Change 2.76% 2.07%
Operating Profit $128.0M $246.0M
YoY Change -29.67% 30.16%
Interest Expense $58.00M $65.00M
YoY Change -19.44% -12.16%
% of Operating Profit 45.31% 26.42%
Other Income/Expense, Net -$1.000M -$2.000M
YoY Change -88.89% -91.3%
Pretax Income $559.0M -$32.00M
YoY Change -150.96% -59.49%
Income Tax $195.0M $18.00M
% Of Pretax Income 34.88%
Net Earnings $364.0M -$50.00M
YoY Change -133.21% -48.45%
Net Earnings / Revenue 35.34% -4.22%
Basic Earnings Per Share $0.74 -$0.10
Diluted Earnings Per Share $0.73 -$0.10
COMMON SHARES
Basic Shares Outstanding 494.3M shares 494.2M shares
Diluted Shares Outstanding 497.7M shares 494.2M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $490.0M $416.0M
YoY Change 32.79% 13.35%
Cash & Equivalents $490.0M $416.0M
Short-Term Investments
Other Short-Term Assets $340.0M $904.0M
YoY Change -8.36% 144.32%
Inventory $1.632B $1.611B
Prepaid Expenses
Receivables $840.0M $999.0M
Other Receivables $64.00M $81.00M
Total Short-Term Assets $3.366B $4.011B
YoY Change -5.58% 9.83%
LONG-TERM ASSETS
Property, Plant & Equipment $979.0M $949.0M
YoY Change -1.31% -5.76%
Goodwill $4.625B $4.480B
YoY Change -5.65% -25.83%
Intangibles $4.011B $4.000B
YoY Change -10.37% -14.49%
Long-Term Investments $25.00M $24.00M
YoY Change -10.71% -11.11%
Other Assets $302.0M $324.0M
YoY Change -26.34% -22.67%
Total Long-Term Assets $9.917B $9.753B
YoY Change -8.0% -19.69%
TOTAL ASSETS
Total Short-Term Assets $3.366B $4.011B
Total Long-Term Assets $9.917B $9.753B
Total Assets $13.28B $13.76B
YoY Change -7.4% -12.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $259.0M $291.0M
YoY Change -12.5% -17.8%
Accrued Expenses
YoY Change
Deferred Revenue $333.0M $356.0M
YoY Change -6.46% 7.23%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $44.00M $213.0M
YoY Change 12.82% 446.15%
Total Short-Term Liabilities $1.321B $1.370B
YoY Change 4.43% 6.7%
LONG-TERM LIABILITIES
Long-Term Debt $4.313B $5.463B
YoY Change -26.52% -9.3%
Other Long-Term Liabilities $587.0M $465.0M
YoY Change 35.88% 13.14%
Total Long-Term Liabilities $4.900B $5.928B
YoY Change -22.25% -7.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.321B $1.370B
Total Long-Term Liabilities $4.900B $5.928B
Total Liabilities $6.760B $7.822B
YoY Change -17.66% -6.61%
SHAREHOLDERS EQUITY
Retained Earnings -$1.942B -$2.306B
YoY Change -9.55% 119.41%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.523B $5.942B
YoY Change
Total Liabilities & Shareholders Equity $13.28B $13.76B
YoY Change -7.4% -12.86%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $364.0M -$50.00M
YoY Change -133.21% -48.45%
Depreciation, Depletion And Amortization $170.0M $162.0M
YoY Change -1.73% -8.47%
Cash From Operating Activities $162.0M $200.0M
YoY Change -18.18% 227.87%
INVESTING ACTIVITIES
Capital Expenditures $50.00M $34.00M
YoY Change 51.52% -19.05%
Acquisitions
YoY Change
Other Investing Activities $1.294B $1.000M
YoY Change -43233.33% -200.0%
Cash From Investing Activities $1.244B -$33.00M
YoY Change -3555.56% -23.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.340B -93.00M
YoY Change 753.5% -338.46%
NET CHANGE
Cash From Operating Activities 162.0M 200.0M
Cash From Investing Activities 1.244B -33.00M
Cash From Financing Activities -1.340B -93.00M
Net Change In Cash 66.00M 74.00M
YoY Change 1220.0% 29.82%
FREE CASH FLOW
Cash From Operating Activities $162.0M $200.0M
Capital Expenditures $50.00M $34.00M
Free Cash Flow $112.0M $166.0M
YoY Change -32.12% 773.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Interest Expense
InterestExpense
65000000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
74000000 usd
us-gaap Interest Expense
InterestExpense
131000000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2000000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23000000 usd
us-gaap Costs And Expenses
CostsAndExpenses
2409000000 usd
us-gaap Costs And Expenses
CostsAndExpenses
2285000000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-79000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29000000 usd
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
1216000000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
1136000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-97000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18000000 usd
us-gaap Net Income Loss
NetIncomeLoss
6000000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
494200000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
492600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
493700000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
491800000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
494200000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
492600000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
493700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
492700000 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-97000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18000000 usd
us-gaap Net Income Loss
NetIncomeLoss
6000000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-9000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
29000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
23000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-19000000 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-66000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
2000000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-293000000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
132000000 usd
CY2024Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
2000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
2000000 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
6000000 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
2000000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-77000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
29000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-276000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
111000000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-127000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-294000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
117000000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
416000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
352000000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
999000000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
842000000 usd
CY2024Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
81000000 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
168000000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
1611000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1735000000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
277000000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
310000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
328000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
25000000 usd
elan Asset Impairment Charges Including Inventory Write Down
AssetImpairmentChargesIncludingInventoryWriteDown
61000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-84000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
16000000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1184000000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1057000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2389000000 usd
elan Contract With Customer Liability Revenue Recognized Including Current Year Additions
ContractWithCustomerLiabilityRevenueRecognizedIncludingCurrentYearAdditions
387000000 usd
elan Contract With Customer Liability Increase From Cash Receipts
ContractWithCustomerLiabilityIncreaseFromCashReceipts
379000000 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
356000000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1184000000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1057000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2389000000 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
492845216 shares
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-32000000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000000 usd
us-gaap Interest Expense
InterestExpense
138000000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11000000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6223000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
32000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-98000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
58000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4000000 usd
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 reporting_unit
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-68000000 usd
CY2024Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
627000000 usd
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
4011000000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3407000000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
4480000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
5094000000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4000000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4494000000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
324000000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
341000000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
949000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1026000000 usd
CY2024Q2 us-gaap Assets
Assets
13764000000 usd
CY2023Q4 us-gaap Assets
Assets
14362000000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
291000000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
270000000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
356000000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
367000000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
213000000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
38000000 usd
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
510000000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
566000000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1370000000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1241000000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5463000000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5736000000 usd
CY2024Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
524000000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
567000000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
465000000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
595000000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
7822000000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
8139000000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
494182138 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
494182138 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
492845216 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8790000000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8777000000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2306000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2288000000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-542000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-266000000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
5942000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6223000000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13764000000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14362000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7289000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
103000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
82000000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
7480000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-97000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
29000000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8000000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7420000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-199000000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-50000000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-77000000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13000000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
5942000000 usd
us-gaap Net Income Loss
NetIncomeLoss
6000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
350000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
21000000 usd
elan Asset Impairment Charges Including Inventory Write Down
AssetImpairmentChargesIncludingInventoryWriteDown
0 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
155000000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
473000000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-39000000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
12000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
202000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
66000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
5000000 usd
us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
66000000 usd
us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
0 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
14000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1000000 usd
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
25000000 usd
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
32000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-15000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-5000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-120000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
213000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-22000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-9000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
64000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
352000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
345000000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
416000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
367000000 usd
us-gaap Basis Of Accounting
BasisOfAccounting
<div><span style="color:#0071cd;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 1. Basis of Presentation and Summary of Significant Accounting Policies</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have prepared the accompanying unaudited condensed consolidated financial statements in accordance with the SEC requirements for interim reporting. As permitted under those rules, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the U.S. (GAAP) have been condensed or omitted. The information included in this Form 10-Q should be read in conjunction with our consolidated financial statements and accompanying notes for the year ended December 31, 2023, included in our </span><span style="color:#0071cd;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1739104/000173910424000009/elan-20231231.htm" style="color:#0071cd;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">2023 Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In addition, results for interim periods should not be considered indicative of results for any other interim period or for the full year ending December 31, 2024, or any other future period. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In our opinion, the financial statements reflect all adjustments (including those that are normal and recurring) that are necessary for fair presentation of the results of operations for the periods shown. In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosures at the date of the financial statements and during the reporting period. Actual results could differ from those estimates. Certain reclassifications of prior year information have been made to conform to the current year's presentation.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The significant accounting policies set forth in Note 2 to the consolidated financial statements in our </span><span style="color:#0071cd;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1739104/000173910424000009/elan-20231231.htm" style="color:#0071cd;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">2023 Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and the footnotes herein appropriately represent, in all material respects, the current status of our accounting policies.</span></div>
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
367000000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
324000000 usd
elan Contract With Customer Liability Revenue Recognized Including Current Year Additions
ContractWithCustomerLiabilityRevenueRecognizedIncludingCurrentYearAdditions
440000000 usd
elan Contract With Customer Liability Increase From Cash Receipts
ContractWithCustomerLiabilityIncreaseFromCashReceipts
446000000 usd
elan Contract With Customer Liability Foreign Currency Translation
ContractWithCustomerLiabilityForeignCurrencyTranslation
5000000 usd
elan Contract With Customer Liability Foreign Currency Translation
ContractWithCustomerLiabilityForeignCurrencyTranslation
0 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
332000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2314000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2314000000 usd
CY2024Q2 us-gaap Restructuring Charges
RestructuringCharges
4000000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Restructuring Charges
RestructuringCharges
43000000 usd
us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2024Q2 elan Business Combination And Disposal Group Related Costs
BusinessCombinationAndDisposalGroupRelatedCosts
10000000 usd
CY2023Q2 elan Business Combination And Disposal Group Related Costs
BusinessCombinationAndDisposalGroupRelatedCosts
35000000 usd
elan Business Combination And Disposal Group Related Costs
BusinessCombinationAndDisposalGroupRelatedCosts
17000000 usd
elan Business Combination And Disposal Group Related Costs
BusinessCombinationAndDisposalGroupRelatedCosts
75000000 usd
CY2024Q2 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
61000000 usd
CY2023Q2 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
61000000 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2024Q2 elan Other Restructuring Costs Noncash
OtherRestructuringCostsNoncash
5000000 usd
CY2023Q2 elan Other Restructuring Costs Noncash
OtherRestructuringCostsNoncash
0 usd
elan Other Restructuring Costs Noncash
OtherRestructuringCostsNoncash
5000000 usd
elan Other Restructuring Costs Noncash
OtherRestructuringCostsNoncash
0 usd
CY2024Q2 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
80000000 usd
CY2023Q2 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
35000000 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
126000000 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
75000000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
777000000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
857000000 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
788000000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
814000000 usd
CY2024Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
109000000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
128000000 usd
CY2024Q2 us-gaap Inventory Gross
InventoryGross
1674000000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
1799000000 usd
CY2024Q2 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
63000000 usd
CY2023Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
64000000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
1611000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1735000000 usd
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
43000000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
50000000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
5676000000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
5774000000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
213000000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
38000000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5463000000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5736000000 usd
CY2024Q2 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
84000000 usd
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
24000000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
26000000 usd
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
6136000000 usd
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
1042000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
5094000000 usd
us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
458000000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-156000000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
4480000000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000000 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.613
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.230
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.074
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.799
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2000000 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.613
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.074
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.230
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.799
CY2023Q4 us-gaap Litigation Reserve
LitigationReserve
0 usd
CY2024Q2 us-gaap Litigation Reserve
LitigationReserve
0 usd
CY2024Q2 elan Lessee Operating Lease Lease Not Yet Commenced Liability To Be Paid
LesseeOperatingLeaseLeaseNotYetCommencedLiabilityToBePaid
378000000 usd
CY2024Q2 us-gaap Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1
LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
P25Y
CY2024Q2 elan Tax Incremental Financing Estimated Total Incentive To Be Funded
TaxIncrementalFinancingEstimatedTotalIncentiveToBeFunded
64000000 usd
CY2021Q4 elan Tax Incremental Financing Commitment Amount
TaxIncrementalFinancingCommitmentAmount
64000000 usd
CY2022Q4 elan Tax Incremental Financing Amount Refunded
TaxIncrementalFinancingAmountRefunded
15000000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
494200000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
492600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
493700000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
491800000 shares
CY2024Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
900000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
494200000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
492600000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
493700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
492700000 shares
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3500000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3500000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1800000 shares
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001739104-24-000027-index-headers.html Edgar Link pending
0001739104-24-000027-index.html Edgar Link pending
0001739104-24-000027.txt Edgar Link pending
0001739104-24-000027-xbrl.zip Edgar Link pending
a2firstamendmenttoapadated.htm Edgar Link pending
elan-20240630.htm Edgar Link pending
elan-20240630.xsd Edgar Link pending
elan-20240630_g1.jpg Edgar Link pending
elan-20240630_def.xml Edgar Link unprocessable
ex311elanco-20240630xceoce.htm Edgar Link pending
ex312elanco-20240630xcfoce.htm Edgar Link pending
ex32elanco-20240630xsectio.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
elan-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
elan-20240630_htm.xml Edgar Link completed
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
elan-20240630_cal.xml Edgar Link unprocessable
elan-20240630_lab.xml Edgar Link unprocessable